General Atlantic’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306M | Buy |
5,733,989
+500,000
| +10% | +$26.7M | 8.43% | 5 |
|
|
2025
Q1 | $212M | Hold |
5,233,989
| – | – | 7.11% | 5 |
|
|
2024
Q4 | $146M | Hold |
5,233,989
| – | – | 5.18% | 6 |
|
|
2024
Q3 | $150M | Hold |
5,233,989
| – | – | 4.27% | 7 |
|
|
2024
Q2 | $123M | Hold |
5,233,989
| – | – | 3.86% | 8 |
|
|
2024
Q1 | $132M | Buy |
5,233,989
+3,448,275
| +193% | +$87.1M | 3.07% | 9 |
|
|
2023
Q4 | $41.7M | Hold |
1,785,714
| – | – | 0.6% | 18 |
|
|
2023
Q3 | $90.3M | Hold |
1,785,714
| – | – | 1.39% | 13 |
|
|
2023
Q2 | $83.4M | Buy |
+1,785,714
| New | +$83.4M | 1.31% | 12 |
|